During the past decade, Hopital Roger Salengro conducted 172 clinical trials. In the 10-year time frame, 172 clinical trials started and 39 clinical trials were completed, i.e. on average, 22.7% percent of trials that started reached the finish line to date. In the past 5 years, 85 clinical trials started and 31 clinical trials were completed. i.e. 36.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Roger Salengro" #1 sponsor was "University Hospital, Lille" with 85 trials, followed by "Pfizer" with 6 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 5 trials sponsored, "Jazz Pharmaceuticals" with 5 trials sponsored and "Biogen" with 5 trials sponsored. Other sponsors include 117 different institutions and companies that sponsored additional 85 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Roger Salengro" #1 collaborator was "Ministry of Health, France" with 7 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 5 trials as a collaborator, "Alzheimer's Association" with 4 trials as a collaborator, "National Institute on Aging (NIA)" with 4 trials as a collaborator and "Accelerating Medicines Partnership (AMP)" with 3 trials as a collaborator. Other collaborators include 68 different institutions and companies that were collaborators in the rest 66 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Roger Salengro" are "Amyotrophic Lateral Sclerosis" (14 trials), "Parkinson Disease" (12 trials), "Alzheimer Disease" (9 trials), "Multiple Sclerosis" (8 trials) and "Alzheimer's Disease" (6 trials). Many other conditions were trialed in "Hopital Roger Salengro" in a lesser frequency.

Most popular intervention types in "Hopital Roger Salengro" are "Drug" (113 trials), "Other" (41 trials), "Device" (26 trials), "Biological" (16 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (45 trials), "placebo" (5 trials), "Eptinezumab" (3 trials), "Gantenerumab" (3 trials) and "JZP-110" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Roger Salengro" are 218 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 79 active trials in "Hopital Roger Salengro". 1 are not yet recruiting, 60 are recruiting, 17 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 104 completed trials in Hopital Roger Salengro, 1 suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Roger Salengro, 4 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 45 trials that are defined as “Not Applicable".